Dr. Dana Diab, MD

Dr. Diab practices at Saint Francis Hospital South in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. Diab's NPI, 1184070245, was assigned on May 9, 2016. Dr. Diab holds New York license 305872.

Dr. Diab's primary practice is Saint Francis Hospital South, at 10501 East 91st Street South, Tulsa, OK 74133 in Tulsa County. The practice phone is (918) 307-6010.

Dr. Diab's primary practice is Saint Francis Hospital South in Tulsa, Oklahoma, part of Saint Francis Health System. Dr. Diab is also affiliated with Saint Francis Hospital. The medical group on file is Integrative Emergency Services. Dmand AI also links Dr. Diab to 3 more hospitals, 9 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diab practices, 10 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Diab's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Diab's licenses on file in 2 states: New York and Wisconsin.

CMS data shows 130 Medicare services from Dr. Diab across 3 procedure codes in 2024, for 135 Medicare patients. Medicare paid $15,935 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 135 Medicare patients who saw Dr. Diab in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diab's median patient age at 63, with 57% women.

In 2024, Dr. Diab wrote 64 Medicare Part D claims for 44 patients. 94% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $48 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Diab for performance year 2024, reported through an alternative payment model (APM). Dr. Diab accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Diab from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $13.